According to recent pan‐cancer analyses that provide a comprehensive characterization of over 11 000 tumors from 33 of the most common cancers, it has become more evident that AMHR2 is highly expressed in some tumors other than those of Müllerian duct origin, such as adrenocortical carcinoma, cutaneous melanoma, pheochromocytoma, malignant pleural mesothelioma, and lung adenocarcinoma (Figure S2). Here, AMHR2 is linked to pheochromocytoma.